Last 7 days
-7.3%
Last 30 days
-12.2%
Last 90 days
8.3%
Trailing 12 Months
-26.6%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-09-15 | Virani Shafique | acquired | 39,960 | 2.22 | 18,000 | chief business officer |
2023-09-15 | Gibson Christopher | gifted | - | - | -10,000 | chief executive officer |
2023-09-15 | Gibson Christopher | acquired | - | - | 10,000 | chief executive officer |
2023-09-15 | Virani Shafique | sold | -155,880 | 8.66 | -18,000 | chief business officer |
2023-09-13 | Secora Michael | sold | -217,318 | 8.6927 | -25,000 | chief financial officer |
2023-09-13 | Secora Michael | acquired | 83,250 | 2.22 | 37,500 | chief financial officer |
2023-09-12 | Secora Michael | sold | -210,632 | 8.4253 | -25,000 | chief financial officer |
2023-09-12 | Secora Michael | acquired | 83,250 | 2.22 | 37,500 | chief financial officer |
2023-09-06 | Gibson Christopher | acquired | - | - | 20,000 | chief executive officer |
2023-09-06 | Gibson Christopher | sold | -8,836 | 8.8363 | -1,000 | chief executive officer |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-08 | TUCKER ASSET MANAGEMENT LLC | unchanged | - | 73.00 | 680 | -% |
2023-08-21 | OSAIC HOLDINGS, INC. | added | 4.2 | 3,422 | 23,924 | -% |
2023-08-21 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | unchanged | - | 139,000 | 1,303,000 | 0.01% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | added | 60.49 | 524,899 | 1,183,190 | -% |
2023-08-16 | Nuveen Asset Management, LLC | added | 9.76 | 1,568,570 | 8,408,570 | -% |
2023-08-15 | GOLDMAN SACHS GROUP INC | added | 7.91 | 744,218 | 4,313,520 | -% |
2023-08-15 | WELLS FARGO & COMPANY/MN | added | 27.81 | 254,994 | 846,142 | -% |
2023-08-15 | ALLIANCEBERNSTEIN L.P. | unchanged | - | 246,929 | 2,305,700 | -% |
2023-08-15 | CENTAURUS FINANCIAL, INC. | added | 20.13 | 25,000 | 99,000 | 0.01% |
2023-08-15 | LAZARD ASSET MANAGEMENT LLC | reduced | -0.12 | 274,000 | 2,578,000 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
May 22, 2023 | kinnevik ab (publ) | 5.6% | 10,405,668 | SC 13G | |
Feb 14, 2023 | lux capital management, llc | 3.3% | 6,004,722 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 5.54% | 10,057,363 | SC 13G | |
Feb 03, 2023 | blackrock inc. | 5.9% | 10,667,624 | SC 13G | |
Jan 24, 2023 | baillie gifford & co | 13.66% | 24,820,850 | SC 13G/A | |
Oct 31, 2022 | mubadala investment co pjsc | 6.3% | 11,291,937 | SC 13D/A | |
Feb 14, 2022 | data collective iv, l.p. | 3.7% | 5,941,120 | SC 13G | |
Feb 14, 2022 | lux capital management, llc | 8.2% | 13,021,519 | SC 13G |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 21, 2023 | 4 | Insider Trading | |
Sep 19, 2023 | 144 | Notice of Insider Sale Intent | |
Sep 19, 2023 | 4 | Insider Trading | |
Sep 19, 2023 | 4 | Insider Trading | |
Sep 15, 2023 | 144 | Notice of Insider Sale Intent | |
Sep 14, 2023 | 4 | Insider Trading | |
Sep 13, 2023 | 144 | Notice of Insider Sale Intent | |
Sep 12, 2023 | 144 | Notice of Insider Sale Intent | |
Sep 08, 2023 | 4 | Insider Trading | |
Sep 07, 2023 | 4 | Insider Trading |
96.9%
96.9%
86.7%
Y-axis is the maximum loss one would have experienced if RECURSION PHARMACEUTICALS was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | (In Thousands) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 |
Revenue | 7.2% | 49,987 | 46,644 | 39,843 | 28,700 | 18,074 | 12,949 | 10,178 | 10,336 | 8,827 | 25,221 | 3,962 | 3,551 | 3,141 | 2,730 | 2,319 |
Operating Expenses | - | - | - | - | - | - | - | 192,953 | 153,732 | 128,295 | 103,220 | 88,577 | 80,407 | 73,612 | 73,612 | 64,760 |
S&GA Expenses | 8.5% | 90,490 | 83,399 | 81,599 | 80,962 | 77,164 | 69,819 | 57,682 | 46,055 | 37,329 | 28,634 | 25,258 | 23,579 | 21,440 | 22,244 | 18,951 |
R&D Expenses | 9.8% | 186,553 | 169,932 | 155,696 | 160,008 | 152,418 | 143,603 | 135,271 | 107,677 | 90,966 | 74,586 | 63,319 | 56,828 | 52,172 | 51,368 | 45,809 |
Interest Expenses | -3.7% | 52.00 | 54.00 | 55.00 | 57.00 | 168 | 440 | 680 | 831 | 807 | 937 | 989 | 1,097 | 1,444 | 1,224 | 485 |
Net Income | -4.5% | -259,990 | -248,824 | -239,476 | -246,917 | -233,900 | -211,741 | -186,479 | -147,312 | -123,757 | -99,299 | -87,006 | -81,653 | -74,734 | -73,696 | -61,879 |
Net Income Margin | 100.0% | - | -5.33* | -6.01* | -8.60* | -10.38* | -3.94* | -18.32* | -2.88* | -2.49* | - | - | - | - | - | - |
Free Cashflow | 100.0% | - | -272,120 | -120,583 | -133,478 | -113,428 | -75,195 | -198,412 | -127,904 | -105,432 | -117,048 | -74,821 | -74,821 | -71,668 | -74,004 | - |
Balance Sheet | (In Millions) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 |
Assets | 6.3% | 667 | 627 | 701 | 612 | 673 | 734 | 610 | 659 | 699 | 272 | 299 |
Current Assets | -12.4% | 431 | 492 | 570 | 482 | 546 | 619 | 535 | 601 | 648 | 222 | 266 |
Cash Equivalents | -14.2% | 406 | 473 | 550 | 455 | 464 | 518 | 295 | 405 | 643 | 219 | 267 |
Net PPE | -0.3% | 90.00 | 90.00 | 88.00 | 86.00 | 82.00 | 71.00 | 65.00 | 55.00 | 49.00 | 45.00 | 26.00 |
Goodwill | 7455.1% | 61.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | - | - | - | 1.00 |
Liabilities | 0.3% | 198 | 197 | 215 | 223 | 235 | 241 | 67.00 | 60.00 | 56.00 | 57.00 | 57.00 |
Current Liabilities | 23.7% | 114 | 92.00 | 100 | 83.00 | 97.00 | 86.00 | 47.00 | 43.00 | 30.00 | 27.00 | 23.00 |
Shareholder's Equity | 9.0% | 469 | 430 | 486 | 388 | 438 | 494 | 543 | 599 | 643 | - | - |
Retained Earnings | -10.9% | -781 | -704 | -639 | -582 | -521 | -456 | -400 | -335 | -287 | -244 | -213 |
Additional Paid-In Capital | 10.2% | 1,251 | 1,135 | 1,125 | 970 | 959 | 950 | 943 | 934 | 930 | 11.00 | 7.00 |
Shares Outstanding | 7.5% | 207 | 192 | 191 | 174 | 172 | 171 | 170 | 169 | 138 | 23.00 | 22.00 |
Cashflow (Last 12 Months) | (In Thousands) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 |
Cashflow From Operations | -2.5% | -240,072 | -234,228 | -83,524 | -99,934 | -78,441 | -50,471 | -158,614 | -88,883 | -75,291 | -58,337 | -45,399 | -71,962 | -69,032 | -71,268 | -57,042 |
Share Based Compensation | 19.7% | 37,227 | 31,091 | 27,909 | 24,555 | 19,011 | 18,653 | 14,842 | 11,689 | 9,396 | 4,848 | 4,292 | 4,139 | 4,068 | 5,060 | 1,385 |
Cashflow From Investing | -15.7% | 37,612 | 44,605 | 193,249 | 148,985 | -97,872 | -109,024 | -271,744 | -224,092 | -33,645 | -27,472 | -8,740 | -5,532 | -1,446 | -2,736 | -3,910 |
Cashflow From Financing | 0.7% | 155,302 | 154,183 | 154,345 | 10,885 | -2,547 | 458,490 | 458,540 | 464,779 | 705,595 | 242,272 | 246,135 | 314,800 | 12,758 | 23,988 | 120,410 |
Condensed Consolidated Statements of Operations (unaudited) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Revenue | ||||
Revenue | $ 11,017 | $ 7,674 | $ 23,151 | $ 13,007 |
Operating costs and expenses | ||||
Cost of revenue | 9,382 | 14,227 | 21,829 | 22,026 |
Research and development | 55,060 | 38,439 | 101,737 | 70,880 |
General and administrative | 28,290 | 21,199 | 51,165 | 42,273 |
Total operating costs and expenses | 92,732 | 73,865 | 174,731 | 135,179 |
Loss from operations | (81,715) | (66,191) | (151,580) | (122,172) |
Other income, net | 4,989 | 631 | 9,527 | 633 |
Net loss | $ (76,726) | $ (65,560) | $ (142,053) | $ (121,539) |
Per share data | ||||
Net loss per share of Class A, B and Exchangeable common stock, basic (in dollars per share) | $ (0.38) | $ (0.38) | $ (0.71) | $ (0.71) |
Net loss per share of Class A, B and Exchangeable common stock, diluted (in dollars per share) | $ (0.38) | $ (0.38) | $ (0.71) | $ (0.71) |
Weighted-average shares (Class A, B and Exchangeable) outstanding, basic (in shares) | 201,415,475 | 172,212,390 | 198,957,804 | 171,455,595 |
Weighted-average shares (Class A, B and Exchangeable) outstanding, diluted (in shares) | 201,415,475 | 172,212,390 | 198,957,804 | 171,455,595 |
Operating revenue | ||||
Revenue | ||||
Revenue | $ 11,016 | $ 7,653 | $ 23,150 | $ 12,952 |
Grant revenue | ||||
Revenue | ||||
Revenue | $ 1 | $ 21 | $ 1 | $ 55 |
Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 405,870 | $ 549,912 |
Restricted cash | 3,325 | 1,280 |
Other receivables | 3,051 | 2,753 |
Other current assets | 18,774 | 15,869 |
Total current assets | 431,020 | 569,814 |
Restricted cash, non-current | 7,629 | 7,920 |
Property and equipment, net | 89,768 | 88,192 |
Operating lease right-of-use assets | 34,899 | 33,255 |
Intangible assets, net | 42,757 | 1,306 |
Goodwill | 60,516 | 801 |
Other assets, non-current | 110 | 0 |
Total assets | 666,699 | 701,288 |
Current liabilities | ||
Accounts payable | 2,086 | 4,586 |
Accrued expenses and other liabilities | 32,873 | 32,904 |
Unearned revenue | 73,105 | 56,726 |
Notes payable | 676 | 97 |
Operating lease liabilities | 5,219 | 5,952 |
Total current liabilities | 113,959 | 100,265 |
Unearned revenue, non-current | 32,436 | 70,261 |
Notes payable, non-current | 1,155 | 536 |
Operating lease liabilities, non-current | 45,850 | 44,420 |
Deferred tax liabilities | 4,336 | 0 |
Total liabilities | 197,736 | 215,482 |
Commitments and contingencies (Note 7) | ||
Stockholders’ equity | ||
Common stock, $0.00001 par value; 2,000,000,000 shares (Class A 1,989,032,117 and Class B 10,967,883) authorized as of June 30, 2023 and December 31, 2022; 206,737,332 shares (Class A 195,051,012, Class B 7,679,871 and Exchangeable 4,006,449) and 191,022,864 shares (Class A 183,209,655, Class B 7,813,209 and Exchangeable 0) issued and outstanding as of June 30, 2023 and December 31, 2022, respectively | 2 | 2 |
Additional paid-in capital | 1,250,570 | 1,125,360 |
Accumulated deficit | (781,609) | (639,556) |
Total stockholders’ equity | 468,963 | 485,806 |
Total liabilities and stockholders’ equity | $ 666,699 | $ 701,288 |